Yichen Cao

发表

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

D. Auclair, P. Vincent, G. Bollag, 2004, Cancer Research.

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

S. Wilhelm, M. Lynch, Christopher A. Carter, 2006, Cancer research.

Hepatocellular Carcinoma Model PLC / PRF / 5 Tumor Angiogenesis , and Induces Tumor Cell Apoptosis in Sorafenib Blocks the RAF / MEK / ERK Pathway , Inhibits

S. Wilhelm, M. Lynch, Christopher A. Carter, 2006 .

Receptor Tyrosine Kinases Involved in Tumor Progression Activity and Targets the RAF/MEK/ERK Pathway and BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor

D. Auclair, P. Vincent, G. Bollag, 2004 .

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

R. Buttyan, Yichen Cao, A. Katz, 2001, The Prostate.

MYELOID NEOPLASIA AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates ef ﬁ cacy in preclinical models of acute myeloid leukemia

L. Platanias, P. Lyne, R. Stone, 2014 .

Original Articles PREOPERATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION FOR PROSTATE SPECIFIC ANTIGEN PREDICTS TREATMENT FAILURE FOLLOWING RADICAL PROSTATECTOMY

M. Benson, C. Olsson, A. Raffo, 1996 .

AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.

Allan Wu, Paul D Lyne, Xiaolan Zheng, 2014, Blood.

Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models

W. Sellers, Nanxin Li, D. Ruddy, 2017, eLife.

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

M. Lawrence, G. Caponigro, J. Engelman, 2018, Nature Medicine.

AZD1208, a Novel, Potent and Selective Pan PIM Kinase Inhibitor, Demonstrates Efficacy in Models of Acute Myeloid Leukemia

P. Lyne, Jeffrey L. Brown, E. Keeton, 2011 .

Blood‐based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow‐up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy

D. Chopin, M. Benson, C. Olsson, 1999, International journal of cancer.

Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.

A. Shabsigh, A. De la taille, M. Burchardt, 1999, The Journal of urology.

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

R. Buttyan, Yichen Cao, A. Katz, 2001, The Prostate.

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

D. Auclair, P. Vincent, G. Bollag, 2004, Cancer Research.

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

M. Benson, C. Olsson, A. Raffo, 1996, The Journal of urology.